What are the causes of erysipelas?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Erysipelas

Erysipelas is primarily caused by beta-hemolytic streptococci, especially Streptococcus pyogenes (group A streptococci), which enter through breaches in the skin. 1, 2

Pathogenic Organisms

  • Beta-hemolytic streptococci, particularly Streptococcus pyogenes (group A), are the predominant causative organisms 2
  • Less commonly, other streptococci groups (B, C, G) may cause erysipelas 3
  • Staphylococcus aureus is a rare cause, usually associated with previous penetrating trauma 3, 4
  • Other rare infectious agents can cause cellulitis/erysipelas in specific circumstances:
    • Pasteurella species (especially P. multocida) or Capnocytophaga canimorsus following cat or dog bites 3
    • Aeromonas hydrophila after immersion in fresh water 3
    • Vibrio species (particularly V. vulnificus) after saltwater exposure in warm climates 3
    • Occasionally Streptococcus iniae or Erysipelothrix rhusiopathiae 3

Predisposing Factors and Entry Points

Skin Barrier Disruption

  • Trauma to the skin, even minor and clinically inapparent breaks 3
  • Preexisting skin infections such as impetigo or ecthyma 3
  • Ulceration 3
  • Fissured toe webs from maceration or fungal infection (tinea pedis) 3, 5
  • Inflammatory dermatoses such as eczema 3

Local Risk Factors

  • Lymphedema and lymphatic obstruction (strongest risk factor for recurrence with adjusted odds ratio of 19.6) 5
  • Venous insufficiency 3, 4
  • Obesity (adjusted odds ratio of 2.3 for recurrence) 5
  • Previous cutaneous damage 3
  • Intertrigo from fungal infections 6

Surgical Risk Factors

  • Procedures that disrupt lymphatic drainage increase risk, including:
    • Saphenous venectomy 3
    • Axillary node dissection for breast cancer 3
    • Operations for gynecologic malignancies involving lymph node dissection, especially when followed by radiation therapy (radical vulvectomy and radical hysterectomy) 3

Mechanism of Recurrence

  • Erysipelas has a high recurrence rate of up to 40% despite appropriate antibiotic treatment 6
  • Intracellular uptake and persistence of streptococci within epithelial cells, endothelial cells, and macrophages creates reservoirs that are protected from penicillins 6
  • These intracellular reservoirs may serve as endogenous sources for relapses, as penicillins do not reach sufficient bactericidal intracellular concentrations 6
  • Recurrent episodes cause progressive lymphatic damage, resulting in irreversible lymphedema and ultimately elephantiasis nostras 6

Comorbidities Associated with Recurrence

  • Hypertension 7
  • Diabetes 7, 5
  • Overweight/obesity 7, 5
  • Venous insufficiency 7

Clinical Presentation

  • Sudden onset with fever preceding skin manifestations 2
  • Rapidly spreading areas of edema, redness, and heat 3
  • Painful, infiltrated, erythematous plaque with distinct borders 2
  • Sometimes accompanied by lymphangitis and inflammation of regional lymph nodes 3
  • Skin surface may resemble orange peel (peau d'orange) due to superficial cutaneous edema 3
  • Vesicles, bullae, and cutaneous hemorrhage in the form of petechiae or ecchymoses may develop 3
  • Most commonly affects the lower limbs, but can occur on the face 2

Understanding these causes and risk factors is essential for both effective treatment and prevention of recurrence, which remains a significant clinical challenge in the management of erysipelas.

References

Guideline

Erisipela Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Recurrent erysipelas].

Revue medicale de Bruxelles, 1991

Research

Erysipelas of the leg: A cross-sectional study of risk factors for recurrence.

Annales de dermatologie et de venereologie, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.